Ramipril Capsule
Product Images NDC 68382-144

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Ramipril (NDC 68382-144). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structured Product Formula For Ramipril (9eac2e75 3766 4394 A435 547cdc840b42 01)

Chemical structure diagram of Ramipril showing its molecular arrangement including phenyl, ethoxycarbonyl, and carboxyl functional groups.*

FDA Label Image

Figure 1 (9eac2e75 3766 4394 A435 547cdc840b42 02)

A Kaplan-Meier curve illustrating the composite outcome of myocardial infarction, stroke, or death from cardiovascular causes comparing Ramipril and placebo groups over approximately 1600 days of follow-up, showing the proportion of patients affected over time.*

FDA Label Image

Figure 2 (9eac2e75 3766 4394 A435 547cdc840b42 03)

A figure titled 'The Beneficial Effect of Treatment with Ramipril on the Composite Outcome of Myocardial Infarction, Stroke, or Death from Cardiovascular Causes Overall and in Various Subgroups.' The chart presents the relative risk in the Ramipril treatment group versus placebo across different patient subgroups such as cardiovascular disease status, diabetes, age, sex, hypertension, history of coronary artery disease, prior myocardial infarction, cerebrovascular disease, peripheral vascular disease, and microalbuminuria. Data includes number of patients and incidence in placebo group, with a 95% confidence interval illustrated on a horizontal scale.*

FDA Label Image

Ramipril Capsules, 1.25 mg (9eac2e75 3766 4394 A435 547cdc840b42 04)

Ramipril Capsules USP 1.25 mg oral capsules in a 30-count package from Zydus Pharmaceuticals USA Inc. The label includes the NDC number 68382-144-06 and storage, dosage, and safety information. Manufactured by Cadila Healthcare Ltd., India, and distributed by Zydus Pharmaceuticals USA Inc.*

FDA Label Image

Ramipril Capsules, 2.5 mg (9eac2e75 3766 4394 A435 547cdc840b42 05)

Label for Ramipril Capsules, USP 2.5 mg oral capsules by Zydus Pharmaceuticals USA Inc. The label shows the product name, strength, quantity of 100 capsules, and Rx only status. It includes storage instructions and dispensing warnings. Bar code and NDC number 68382-145-01 are visible.*

FDA Label Image

Ramipril Capsules, 5 mg (9eac2e75 3766 4394 A435 547cdc840b42 06)

Ramipril Capsules, USP 5 mg oral capsules in a bottle label format. The label shows the Zydus Pharmaceuticals USA Inc. logo and indicates a quantity of 100 capsules. It includes storage instructions, pharmacist dispensing instructions, and manufacturer details: Cadila Healthcare Ltd., Ahmedabad, India. The label also displays the NDC number 68382-146-01.*

FDA Label Image

Ramipril Capsules, 10 mg (9eac2e75 3766 4394 A435 547cdc840b42 07)

Label for Ramipril Capsules USP 10 mg oral capsules by Zydus Pharmaceuticals USA Inc. The label shows one blue and gray capsule imprinted with 'ZA-46 mg'. It indicates a package containing 100 capsules with Rx only status. Storage instructions and manufacturer details of Cadila Healthcare Ltd., India, are included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.